ITGA2 and posterior cortical atrophy: These results indicate ITGA1, ITGA2 or TEAD1 as a potential independent prognostic marker in distinguishing PCa patients who are classified with the intermediate risks, representing the most difficult patient group in clinic to avoid the overtreatment.